News
Fintel on MSN3d
Goldman Sachs Initiates Coverage of Viking Therapeutics (VKTX) with Neutral RecommendationFintel reports that on April 8, 2025, Goldman Sachs initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...
If you haven’t tried CSR2 yet, don’t go in expecting a Le Mans Ultimate beater - this is definitely the more accessible, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback